Navigation Links
Fox Chase Cancer Center's Ning Wong receives ASCO Cancer Foundation Career Development Award

The American Society of Clinical Oncology Cancer Foundation has selected Yu-Ning Wong, M.D., M.S.C.E., of Fox Chase Cancer Center, as one of 13 clinicians to receive a 2008 Career Development Award. Career Development Awards are presented to physicians in their second, third or fourth year as full-time faculty members in an academic setting. This award marks the third time ASCO has honored Wong's accomplishments since she began her professional career in oncology in 2002.

Wong is an attending physician in Fox Chase Cancer Center's department of medical oncology and holds a dual appointment as an associate member of the Center's divisions of medical science and population science. Her clinical interests include genitourinary malignancies such as kidney, bladder, prostate and testicular cancers. Wong also conducts health services research including cost-effectiveness analysis and research on treatment outcomes.

"I believe it is essential for physicians to understand how we care for cancer patients as a society," said Wong. "I study large national databases to measure the outcomes of men with prostate cancer, and I study outcomes of treatment for colon cancer and breast cancer. I enjoy these endeavors because they encourage me to think about problems from many different angles, an important aspect of being a medical oncologist."

Each of this year's Clinical Development Award winners will receive a three-year grant totaling $200,000 to establish an independent clinical cancer research program. This is the third award ASCO has given Wong. In 2005, she was awarded a Young Investigator Award, which provides grants to leading young clinical oncology researchers in a broad range of specialties worldwide. In 2004, she received an ASCO Merit Award given to fellows who submit high-quality abstracts selected for presentation at the ASCO Annual Meeting.

"We are currently in the longest period of flat and declining federal funding for cancer research to date, and without appropriate investment, the opportunity to develop better treatments for cancer care will be lost or delayed," said Joseph S. Bailes, MD, chair of The ASCO Cancer Foundation Board of Directors. "The ASCO Cancer Foundation supports progress in cancer by funding researchers at all stages of their profession enabling oncology's best and brightest to pursue promising research initiatives."

A board-certified medical oncologist, Dr. Wong joined the Fox Chase medical staff in July 2005 after completing a three-year fellowship in hematology and oncology at the Fox Chase-Temple Cancer Center.

Wong has a bachelor's degree in liberal arts from the University of Virginia and an M.D. from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey in Piscataway, N.J. She completed her residency in internal medicine at Thomas Jefferson University Hospital in Philadelphia. Wong also has a master's of science degree in clinical epidemiology from the University of Pennsylvania.

In addition to her ASCO membership, Wong serves on two disease-specific executive committees for the National Comprehensive Cancer Networkone on the outcomes database in colorectal cancer and one on the outcomes database in breast cancer.


Contact: Karen Mallet
Fox Chase Cancer Center

Related medicine news :

1. Somanetics Announces Share Repurchase Program Increased by $15 Million
2. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend, Authorizes Share Repurchase Program and Announces Election of New Officers
3. DaVita Board of Directors Increases Share Repurchase Authorization
4. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
5. US Army Purchases SeQuals Cutting-Edge Oxygen Generation Technology for MRAP Deployment
6. HealthSouth to Purchase The Rehabilitation Hospital of South Jersey
7. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
8. Saratoga Hospital Purchases Three IDC DR Systems
9. Somanetics Announces Share Repurchase Program
10. Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting
11. Health Fitness Announces $2.5 Million Stock Repurchase Plan
Post Your Comments:
(Date:11/25/2015)... MI (PRWEB) , ... November 25, 2015 , ... In ... Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy ... medical and surgical intensive care units (totaling 30 beds) from May 2014 through October ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Today, Mothers ... our nation’s roadways has dropped below 10,000 for the first time since 2011. In ... 2013. , According to data released by the National Highway Traffic Safety Administration (NHTSA), ...
(Date:11/25/2015)... ... 25, 2015 , ... In honor of Pulmonary Hypertension Awareness ... groups responsible for advancing care for pulmonary hypertension (PH) patients and helping to ... will receive special recognition throughout 2016 as part of PHA’s 25th anniversary celebrations. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Privately ... has undertaken significant expansion of its current state of the art research, development ... PharmaTech’s strategy to increase its manufacturing capacity as well as to support its ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Many people ... fatigue, fuzzy-headedness, weight gain, cold hands, and dry skin. But many people who find ... diet and exercise regimen instead of their thyroid, especially if they don’t have any ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  The American Academy ... Gynecologists (ACOG), and the March of Dimes cheered ... Protecting Our Infants Act of 2015 (S.799), ... of newborns born exposed to drugs, such as ... bill,s introduction, all three organizations have worked together ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
Breaking Medicine Technology: